The adverse renal effects of the non-steroidal antiinflammatory analgesic drugs (NSAID) are serious and well described [1-6]-Most studies have examined the effect of long-term oral NSAID intake prescribed for medical conditions, but there is little work on the acute renal effects of short-term parenteral administration to surgical patients. It is known that animals are more sensitive to the renal effects of NSAID after laparotomy under general anaesthesia [7] . As the use of NSAID after surgery is becoming more common, it is important to identify a potential problem in man.
The adverse renal effects of the non-steroidal antiinflammatory analgesic drugs (NSAID) are serious and well described [1] [2] [3] [4] [5] [6] -Most studies have examined the effect of long-term oral NSAID intake prescribed for medical conditions, but there is little work on the acute renal effects of short-term parenteral administration to surgical patients. It is known that animals are more sensitive to the renal effects of NSAID after laparotomy under general anaesthesia [7] . As the use of NSAID after surgery is becoming more common, it is important to identify a potential problem in man.
The kidney can synthesize most prostaglandins [8] , and-they act as local tissue hormones maintaining blood flow, regulating tubular processes involving electrolytes, and modulating the effect of other renal hormones [9] . The prostaglandins produced in greatest abundance by the kidney are prostacyclin (PGI 2 ) in the cortex and PGE 2 in the medulla [10] .
Vasoconstrictor hormones, including renin, angiotensin, noradrenaline and vasopressin, produce a compensatory increase in the renal synthesis of vasodilator prostaglandins by inducing phospholipase [11] , which breaks down membrane phospholipids to produce the chemical precursor of prostaglandins, arachidonic acid. In some clinical states associated with increased circulating concentrations of vasoconstrictors, which may include surgery, renal blood flow can become dependent on prostaglandins and NSAID may have acute adverse effects [1, 2] .
It is our practice to use i.m. diclofenac in combination with local anaesthetics and i.v. morphine to provide analgesia after major thoracic surgery, including oesophagogastrectomy. Maintenance of correct fluid balance is important because overload may precipitate pulmonary oedema after thoracotomy in these, often malnourished, patients. This was thought to be an appropriate situation in which to investigate the effect of NSAID on postoperative renal function, especially as fluid balance is routinely monitored closely after oesophagogastrectomy.
PATIENTS AND METHODS
The study was approved by the local Ethics Committee. Exclusion criteria were a history of peptic ulcer disease, asthma, previous reactions to NSAID, allergies, evidence of renal insufficiency based on preoperative venous blood sampling and biochemical analysis, diuretic therapy and recent NSAID ingestion. Twenty patients were enrolled after giving informed, written, consent and all had oesophagogastrectomy for carcinoma, performed via a left thoracoabdominal incision. The two drug groups were similar in age, height, weight, sex and surgical blood loss (P = 0.6) (table I) .
A double-blind, randomized, controlled study of the effect of i.m. diclofenac on renal function after major surgery was performed. A control group was included for comparison. Renal function and PGI 2 production were assessed on the day before operation, the day of surgery (day 1), and the day after surgery (day 2). Patients were allocated randomly to receive five i.m. injections of either diclofenac 75 mg or identical placebo. The injections were given at induction of anaesthesia, and 12-hourly thereafter.
The general anaesthetic technique was standardized. Premedication comprised i.m. papaveretum and atropine, anaesthesia was induced with i.v. propofol, suxamethonium was used to facilitate tracheal intubation, the lungs were ventilated with enflurane and nitrous oxide in oxygen and neuromuscular block was maintained with atracurium. At the end of the procedure, neuromuscular block was antagonized with neostigmine and atropine.
Intercostal nerve blocks were performed on each patient before surgery (40 ml of 0.5 % bupivacaine with adrenaline). All patients were given morphine by continuous i.v. infusion at a rate of 1 mg h" 1 after operation and additional i.v. morphine was available at the discretion of one nurse observer. The patients were nursed in a high dependency unit during the study, and each completed a 100-mm visual analogue scale (VAS) for pain intensity (0 = no pain to 100 mm = worst possible pain) on a daily basis, according to normal ward practice.
In the operating theatre, central venous, arterial and urinary catheters were placed to allow routine monitoring and collection of blood and urine samples in the postoperative period.
Fluid therapy was standardized. Surgical blood loss was replaced in the operating theatre with plasma protein solution and normal saline. After surgery, normal saline and 5 % glucose were infused alternately at a rate of 500 ml every 6 h. Central venous pressure was maintained at 5-10 cm H 2 O by the infusion of plasma protein solution.
Before operation, venous blood samples were analysed for creatinine and electrolyte concentrations. On the day before surgery, urine was collected from the time of enrolment into the study. In the postoperative period, urine output was measured for 48 h from the time of induction of anaesthesia.
Venous blood samples were taken on the day of surgery (day 1), and the next day (day 2), centrifuged at 2000 g and the plasma removed. Aliquots of the urine collection from each day were stored with the plasma samples at -20 °C for batch analysis at the end of the study using routine laboratory methods.
Plasma and urine concentrations of creatinine and electrolytes, and osmolality were examined in both groups over the 3-day study period. Urine flow rate, urinary excretion of sodium and potassium, and creatinine and free water clearances were calculated.
It was the practice in the surgical unit involved to give i.v. frusemide 10 mg if urine flow rate was less than 30 ml h~' for two consecutive periods of 1 h. In this study, the number of patients in each group given frusemide were compared.
Previous studies have shown that the renal production of prostacyclin, PGI 2 , can be assessed by measuring the concentration of the product of spontaneous hydrolysis, 6-keto-PGF la , which is stable in urine but in blood is metabolized further to 2,3 dinor 6-keto-PGF M [12] [13] [14] . In this investigation, urinary 6-keto-PGF,, was measured in aliquots of the preoperative collection and of the two 24-h urine volumes collected after surgery. Knowing the urinary volume produced in a given time, we were able to calculate the production per minute of 6-keto-PGF 1(J .
Measurement of 6-keto-PGF )(I was by radioimmunoassay as described previously [15] . Briefly, aliquots of urine were collected and stored at -20 °C until the analysis was performed in a batch. After thawing, urine was acidified and the prostaglandin extracted into ethyl acetate. The assay used a doubleantibody technique as the separation method. The specific antibody for 6-keto-PGF lo was raised in the Department of Pharmacology of the University of Edinburgh, and tritiated 6-keto-PGF, o was obtained from Amersham International Ltd. The interassay and intra-assay coefficients of variation were 15% and 11%, respectively.
Statistical analysis
At the end of the study, the randomization code was broken and the two groups compared. Patient details are given as mean (SD), and other values as mean (SE). The two treatment groups were compared on the day before operation, and on the first (day 1) and second (day 2) days after surgery. Changes in individuals from baseline were examined using analysis of variance and paired t tests. Comparisons between the diclofenac and morphine groups were made using unpaired t tests. Categorical data (whether or not the patient was given frusemide) were analysed using a chi-square test. The sig-> nificance level was set at 5 % and, where appropriate, 95 % confidence intervals (95 % CI) were calculated.
RESULTS
Before surgery, there was no significant difference between the groups in plasma electrolyte concentrations, urine output, electrolyte excretion, creatinine clearance, or 6-keto-PGF, a production (table II) .
Plasma concentrations of sodium, potassium and creatinine, and osmolality (table II) . There was no significant difference between the diclofenac and placebo groups at any time, although the diclofenac group tended to have greater potassium concentrations than the control group on the first day after operation: five of the diclofenac group had potassium concentrations in excess of the laboratory upper limit of normal (4.7 mmol litre" 1 ) and in three the concentrations were greater than 5 mmol litre" 1 . In comparison, only two patients in the control group had increased potassium concentrations on day 1, 
In the control group, there was a significant reduction from preoperative values in plasma sodium concentration on day 1 (P = 0.03, 95%CI -7 to -0.04 mmol litre" (table III) . There was no significant difference in the amount of i.v. fluids given to the two groups on day 1 or day 2 (P = 0.9 and 0.5, respectively). The diclofenac group tended to have a greater positive fluid balance on the first day after operation, although the difference was not statistically significant.
Urine output (table III) . Urine production was significantly less in the diclofenac group on day 1 compared with the control group (P = 0.02, 95 %CI -0.5 to -0.06 ml min" 1 ). On day 2, there was no significant difference between the groups.
Sodium and potassium excretion (table III) . Urinary excretion of sodium was significantly less in the diclofenac group on day 1 (P = 0.01,95 %CI -62 to -8 umol min" 1 ). Potassium excretion increased in both groups in the postoperative period, but the increase was greater in the control group on day 1, so that potassium excretion was less in the diclofenac group on that day (P = 0.04, 95%CI -49 to -1 umol min" 1 ) On day 2, there was no statistically significant difference between the groups.
Creatinine clearance (table III) . Preoperative creatinine clearances were not significantly different in the two groups. In the control group, there was a significant increase in creatinine clearance on day 1 (P = 0.02, 95 %CI 6-53 ml min" 1 ), but there was no change in the diclofenac group.
Free water clearance (table III) . There was a statistically significant difference between the groups only on day 1, when the control group retained more free water than the diclofenac group (P = 0.04, 95 %CI 0.01-0.8 ml min" 1 ). Urinary 6-keto-PGF la ( fig. 1, table IV) . Urinary excretion of 6-keto-PGF la increased markedly in the control group after surgery, especially on day 1. In contrast, the diclofenac group showed little change. Consequently, urinary 6-keto-PGF la excretion was significantly greater in the control group on days 1 and 2 (P = 0.02 and 0.003, respectively). Frusemide. Diuretic therapy was required more often after surgery in the diclofenac group; nine patients were given frusemide, in comparison with only four in the control group (P = 0.02).
Analgesia. There was no significant difference between the pain scores of the two groups during the study. For example, on the day after operation the mean VAS scores were 27(9) mm and 31(8) mm (P = 0.8) for the control and diclofenac groups, respectively. The control group, however, required more morphine during the study (62(5.3) mg) than the diclofenac group (49(7.7) mg), although this difference was not significant (P = 0.2, 95%CI -7 to 32 mg).
Adverse events (table V) . One patient in the diclofenac group was withdrawn from the study after 18 h because of concern about persistently small volumes of urine (averaging less than 20 ml h" 1 ). Two doses of diclofenac had been given before the patient was withdrawn. Despite adequate fluid loading and frusemide administration, i.v. dopamine was required to promote an acceptable urine flow. After withdrawal of diclofenac and commencement of dopamine, renal function improved and the patient recovered completely. Blood analysis revealed a marked increase in creatinine and potassium concentration on day 1. Plasma potassium concentration on day 1 was particularly great-5.4 mmol litre" 1 (laboratory upper limit of normal 4.7 mmol litre" 1 ). It should also be noted that, although the preoperative creatinine concentration was within normal limits (55-150 umol litre" 1 ), this patient had a reduced preoperative creatinine clearance (45 ml min" 1 ) which decreased by almost 50 % on the first day after operation. In contrast to the pattern found in the control patients, urinary 6-ketoPGFi 0 continued to increase in this patient from day 1 to day 2, after diclofenac was withdrawn.
DISCUSSION
Urinary 6-keto-PGF la production increased markedly in the postoperative period in the control group, whereas there was no change with diclofenac ( fig. 1,  table IV) . Urinary 6-keto-PGF lo is an accepted indicator of renal PGI 2 production [12] [13] [14] . To our knowledge, this is the first report of such an increase in renal PGI 2 production after surgery in humans, and of the effect of diclofenac.
Prostaglandins are thought to act as local vasodilators which maintain renal function in clinical conditions associated with large concentrations of circulating vasoconstrictors (e.g. congestive cardiac failure, hypovolaemia), when blood flow can become "prostaglandin dependent" [1, 2] . On the basis of this study, it may be that renal prostaglandins are important after surgery. As renal PGI 2 production peaked on the first day after operation in the control group, this effect may be most important in the immediate postoperative period.
As there is inevitably tissue damage and disruption after oesophagogastrectomy, which could release many factors including prostaglandins, it should be established that the urinary 6-ket0-PGF lo measured in this study did represent renal, not systemic, PGI 2 production. There is no published work on the effect on anaesthesia and surgery on urinary metabolites of PGI,, but studies have been reported on plasma 6-keto-PGF la , which may reflect systemic production of PGIj to some extent. Minor surgery does not increase plasma 6-keto-PGF la , whether using general [16] , or spinal [17] anaesthesia. Plasma 6-keto-PGF ltI concentration increases after surgical incision of laparotomy, but decreases within 40 min [18] , and this is prevented by pretreatment with ibuprofen [19] . Such studies indicate that systemic PGI, production is not increased greatly after surgery. The increase in urinary 6-keto-PGF ]01 observed in this study may therefore truly reflect an increase in renal PGI, production after major surgery. In order to investigate this further, it would be useful to observe simultaneously both urinary 6-keto-PGF la and 2,3 dinor 6-keto-PGF 1(I (the final urinary excretion metabolite of systemic PGI 2 production) after surgery to represent production of renal and systemic PGI S , respectively, as used in recent studies of other clinical problems [14] .
In this study, diclofenac therapy was associated with significantly reduced urine flow and sodium and potassium excretion on the first day after operation, but on the next day there was no difference (table  III) . Renal prostaglandins increase urinary sodium excretion [20, 21] , and diclofenac could have produced sodium retention by inhibiting this. PGI 2 stimulates renin release in man [22] and, by preventing this, diclofenac could have impaired potassium excretion. In the postoperative period there is presumably a significant potassium load presented to the kidneys, which has to be excreted to avoid hyperkalaemia.
Creatinine clearance may not be a reliable indicator of glomerular filtration rate after surgery, when plasma creatinine concentrations could be changing as a result of muscle damage. Indeed, creatinine clearance increased in the control group after operation. Inulin and para-amino hippuric acid clearance studies may be more useful.
Because NSAID potentiate vasopressin [2, 9, 11, 23] it may have been expected that the diclofenac group would retain more fluid, but in fact the control group conserved more free water on the first day after operation (table III) . This was reflected in the tendency for plasma osmolality to decrease in the control group (table II) . Other factors, including pain intensity and morphine administration, may be involved, as they are known to increase vasopressin release.
Frusemide was given more often to patients in the diclofenac group. Although it would have been desirable to control the administration of diuretics during the study, in practice it was not possible to do so. The observed differences between the groups in urine flow and electrolyte excretion may have been even greater if frusemide had not been given.
Although diclofenac impaired renal function on the first day after surgery, the results of this study indicate that this effect was short lived. Urine output, urinary sodium and potassium excretion and free water clearance were not significantly different with diclofenac on the second day after surgery (table  III) , although renal PGI 2 production was still inhibited by diclofenac at that time ( fig. 1, table IV) . This may indicate that renal prostaglandins are involved in maintaining renal function for perhaps up to 1 day after surgery, but thereafter their importance may be diminished. Consequently, any adverse renal effects of NSAID given during surgery may be expected to occur in this period. It may be prudent to avoid the use of NSAID if there is a significant _risk o£ intraoperative haemorrhage, as renal prostaglandins may be especially important in maintaining kidney function during episodes of hypotension.
The patient withdrawn from the study had marked impairment of renal function which became obvious after only two doses of diclofenac (table V) . Although this patient had a normal preoperative plasma creatinine concentration (101 umol litre" 1 ), subsequent analysis revealed that creatinine clearance was reduced (45 ml min" 1 ), suggesting that there was pre-existing renal impairment. Creatinine clearance is not measured routinely in such patients before surgery, and in this work the result was analysed only after completion of the study. The deterioration in renal function seen in this patient may have resulted from diclofenac, as it was similar to the effect seen when NSAID were given to patients with mild, asymptomatic renal failure [4] . This emphasizes the importance of .monitoring renal function when NSAID are given to patients at risk of adverse events, with subclinical renal impairment, despite normal blood concentrations of creatinine. The patients in this study were elderly, and had major surgery for a debilitating disease. It is likely that this group would be particularly susceptible to NSAIDinduced renal toxicity [5] .
